🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

Recruitingn/aAges 18 Years - anyAllAnkara University
NCT07345247 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Radiation segmentectomy (RS) refers to selective infusion of Y-90 microspheres to the tumor bearing hepatic segment of hepatic artery. Majority of the data on RS is based on the Glass microspheres experience. Due to different properties of Resin and Glass microspheres description of dose limits to the segment for effectiveness of treatments with Resin microspheres are needed. Based on this background in this study it is aimed to evaluate the safety and efficacy of RS with resin microspheres in HCC patients. Secondly, it is planned to describe the dose limits for complete radiological response.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged ≥18 years * Underwent RE as a RS intent (have single or \<3 tumors in same or neighboring 2 segments) for the treatment of HCC or metastatic tumor to liver. * Presence of extrahepatic disease * Tumor size less than 8 cm * Child Pugh Score \<B9 Exclusion Criteria: * Presence of macrovascular invasion, * Presence of extrahepatic disease, * Cholangiocarcinoma or mixed HCC-cholangiocarcinoma * Not willing to attend follow-up visits.
💊

What it tests

  • Not listed
📍

Where

20 sites
Acibadem Adana Hospital
Adana, Turkey (Türkiye)
Adana City Hospital
Adana, Turkey (Türkiye)
Cukurova University
Adana, Turkey (Türkiye)
Bilkent City Hospital
Ankara, Turkey (Türkiye)
Gulhane Education and Research Hospital
Ankara, Turkey (Türkiye)
Hacettepe University
Ankara, Turkey (Türkiye)
Pamukkale University
Denizli, Turkey (Türkiye)
Gazi Yasargil Education and Research Hospital
Diyarbakır, Turkey (Türkiye)

…and 12 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy